Shares of German biotechnology company CureVac nearly third in their Nasdaq debut Friday, marking the first stock market debut of a company developing a potential vaccine to combat the new coronavirus. The stock opened at $ 44 per share, up from the initial public offering price of $ 16 per …
Read More »Duck Creek’s stock opens 56% above its IPO price
Duck Creek Technologies Inc.’s share of DCT, + 52.22% began its public life with a major rally, as the initial trade was 55.6% above the initial price of the officially offered $ 27, which was above the previously expected range. The Boston-based software-as-a-service (SaaS) company for the real estate and …
Read More »Ant Group makes pre-list submission in China for blockbuster IPO
PHILO PHOTO: The logo of Ant Financial Services Group, the financial subsidiary of Alibaba, is displayed at its headquarters in Hangzhou, Zhejiang Province, China January 24, 2018. Image taken January 24, 2018. REUTERS / Shu Zhang HONG KONG (Reuters) – Ant Group, the fintech charm of Chinese e-commerce company Alibaba …
Read More »Coronavirus vaccine developer CureVac raises $ 213 million in IPO
An employee of the German biopharmaceutical company CureVac, demonstrates research into a vaccine for coronavirus (COVID-19) at a laboratory in Tuebingen, Germany, March 12, 2020. Andreas Gebert | REUTERS CureVac raised $ 213 million in its initial public offering (IPO) in New York on Thursday, said a person familiar with …
Read More »Airbnb plans to confidentially register for IPO this month
Airbnb plans to file a confidential complaint with the SEC this month to go public, a source familiar with the matter confirmed to CNBC. Shares could start at the end of the year. Airbnb declined to comment. The Wall Street Journal first reported the news of their brand debut. The …
Read More »